Effects of immunosuppressive agents on the hemostatic system in normal dogs

Journal of Veterinary Internal Medicine
John M ThomasonAndrew J Mackin

Abstract

In dogs, the effects of immunosuppressive medications on hemostasis are not well known. The objective was to determine the effects of immunosuppressive medications on primary and secondary hemostasis. Our hypothesis was that cyclosporine and prednisone would increase markers of hypercoagulability and thromboxane synthesis, while azathioprine, mycophenolate mofetil, and leflunomide would have minimal effects on hemostasis. Eight healthy dogs. A randomized, cross-over study used aggregometry, the PFA-100 platelet function analyzer, viscoelastometry, platelet count, and prothrombin and activated partial thromboplastin times to evaluate hemostasis during the administration of prednisone, azathioprine, cyclosporine, mycophenolate mofetil, and leflunomide for 1 week each at standard oral doses. Urine 11-dehydro-thromboxane-B2 (11-dTXB2 ) and 6-keto-prostaglandin-F1α (6-keto-PGF1α ) concentrations, normalized to urine creatinine concentration, were measured. The aggregometry amplitude decreased from 51 ± 21 to 27 ± 14 (P = .002) during leflunomide treatment (ADP activation), but there were no differences in amplitude (P = .240) for any medications when platelets were activated with collagen. For all medications, there were no signific...Continue Reading

References

Jan 1, 1979·Thrombosis Research·G J JohnsonJ G White
Dec 1, 1987·Kidney International·A A GraceP Dandona
Jul 1, 1986·Journal of Applied Physiology·C A HalesW D Watkins
Jun 1, 1997·Hypertension·H J OskarssonM T Olivari
Sep 24, 1999·Journal of the American Animal Hospital Association·M E ReimerL D Warnick
Mar 22, 2001·Kidney International·M AvernaG Davì
May 9, 2001·American Journal of Veterinary Research·M B Callan, U Giger
May 22, 2001·Journal of the American Animal Hospital Association·J C Scott-MoncrieffM B Brooks
Oct 3, 2002·Circulation·Piotr SobieszczykSamuel Z Goldhaber
Jan 23, 2004·Journal of the American Veterinary Medical Association·Sybille A MillerAnne S Hale
Jun 25, 2005·Journal of Clinical Pathology·H ManiE Lindhoff-Last
Jan 24, 2006·American Journal of Veterinary Research·Wendy I BaltzerDavid A Williams
Aug 2, 2011·American Journal of Veterinary Research·Crystal M HohJulie K Byron
Sep 9, 2011·Veterinary Immunology and Immunopathology·C J PiekL C Penning
Oct 4, 2011·American Journal of Veterinary Research·Sarah K FlintR Darren Wood
Nov 19, 2011·Veterinary Clinical Pathology·Lara J RoseChristian Bédard
Oct 31, 2012·Journal of Veterinary Internal Medicine·J ThomasonA Mackin
Jan 1, 2013·BMC Veterinary Research·Wendy I BaltzerErica C McKenzie
Jan 3, 2013·Journal of Veterinary Internal Medicine·J W Swann, B J Skelly
Jan 2, 2014·BMC Veterinary Research·Felipe Gazza RomãoRegina Kiomi Takahira
Apr 15, 2015·Journal of Veterinary Internal Medicine·L KiddN Mackman
Sep 24, 2015·Veterinary Clinical Pathology·Shauna L BloisGabrielle Monteith
May 9, 2016·Journal of Veterinary Internal Medicine·J ThomasonA Mackin

❮ Previous
Next ❯

Citations

May 3, 2019·Platelets·Camilla Brødsgaard NielsenPernille Just Vinholt
Apr 5, 2020·Journal of Veterinary Internal Medicine·John ThomasonJacqueline C Whittemore
Dec 6, 2019·Frontiers in Veterinary Science·John M ThomasonJacqueline C Whittemore
Dec 4, 2021·Journal of Veterinary Internal Medicine·Elizabeth A ConwayAlison E Ridyard

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA

Software Mentioned

SAS
/ LINK
AGGRO
SonoClot
Signature Viewer Viewer

Related Concepts

Related Feeds

Blood Coagulation Signaling Pathways

Coagulation is the process by which a blood clot is formed. This process includes both the formation of a platelet plug as well as a cascade of clotting factors resulting in the formation of fibrin strands. Find the latest research on coagulation signaling pathways here.

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.